Aktiv Pharma Group
Chemicals & Related Products · Colorado, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
100 Technology Dr Ste 200A, Broomfield, ...Phone Number
(720) 612-4236Website
www.aktivpharmagroup.comRevenue
$7.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Aktiv Pharma Group
AktiVaxTM is creating a paradigm shift in vaccine delivery that will solve vaccine partners problems, costs, and complexities by providing an alternative to the traditional syringe and vial system. AktiVaxs solution involves a three-pillared approach: expertise in cost-effective, dry vaccine formulation; differentiated delivery devices; and efficient manufacturing for rapid market distribution. The company's proposition has already attracted a number of vaccine partners representing a significant portion of the $30 billion vaccine industry. The company believes that the company's solution will create a new standard of care in the vaccine market.Explore more
Popular SearchesAktivaxAktiVax IncAktiv Pharma GroupAktiv Pharma Group IncSIC Code 28,283NAICS Code 32,325Show moreAktiv Pharma Group Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aktiv Pharma Group your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Aktiv Pharma Group
Product Launch: Get notified when Aktiv Pharma Group launches new products
Check if Aktiv Pharma Group has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Aktiv Pharma Group, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Aktiv Pharma Group recently announced quarterly report
Check out if Aktiv Pharma Group is spiking on competitors!
Click to see if Aktiv Pharma Group had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Aktiv Pharma Group has new funding data
Recommended Actions
Reach out to Masked Content who joined Aktiv Pharma Group as Masked Content
Find 3 more new buyers
Compare Similar Companies to Aktiv Pharma Group
Compare insights from companies similar to Aktiv Pharma Group, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Aktiv Pharma Group is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Aktiv Pharma Group is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Aktiv Pharma Group.
Aktiv Pharma Group financials insights
Gather financial insights about Aktiv Pharma Group, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$350K
Aktiv Pharma Group Tech Stack
A closer look at the technologies used by Aktiv Pharma Group
Most Recent Scoops
Facilities Relocation / Expansion
Layoffs
Facilities Relocation/Expansion, Facilities Management
Open Position
Open Position
Open Position
Open Position
Aktiv Pharma Group News & Media
Aktiv Pharma Group to Participate in the FDA Emerging Technology Program
Aktiv Pharma Group's novel glass-free primary drug container technology for sterile injectable pharmaceutical products has been accepted into the Federal Food and Drug Administration (FDA) Emerging Technology Program. (PRWeb September 26, 2022) Read the full story at https://www.prweb.com/releases/2022/09/prweb18919146.htmAktiv Pharma Group to Participate in the FDA Emerging Technology...
Aktiv Pharma Group's novel glass-free primary drug container technology for sterile injectable pharmaceutical products has been accepted into the Federal Food and Drug Administration (FDA)... (PRWeb September 25, 2022) Read the full story at https://www.prweb.com/releases/2022/9/prweb18919146.htmAktiv Pharma Group receives grant funding to develop tranexamic acid autoinjector
Aktiv Pharma Group announces a grant award from the Department of Defense to further advance the development of their tranexamic acid autoinjector, targeting proposed indications related to prehospital treatment of severe bleeding. (PRWeb August 02, 2022) Read the full story at https://www.prweb.com/releases/2022/08/prweb18757078.htm
Read more news
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aktiv Pharma Group
Sign Up For FreeTo access detailed company insights
AktiVaxTM is creating a paradigm shift in vaccine delivery that will solve vaccine partners problems, costs, and complexities by providing an alternative to the traditional syringe and vial system. AktiVaxs solution involves a three-pillared approach: expertise in cost-effective, dry vaccine formulation; differentiated delivery devices; and efficie... Read More
